{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:05:51Z","timestamp":1791216351871,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8-9","license":[{"start":{"date-parts":[[2009,11,26]],"date-time":"2009-11-26T00:00:00Z","timestamp":1259193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,26]],"date-time":"2009-11-26T00:00:00Z","timestamp":1259193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Aging of the National Institutes of Health","award":["P50 AG05681"],"award-info":[{"award-number":["P50 AG05681"]}]},{"name":"National Institute of Aging of the National Institutes of Health","award":["P01 AG03991"],"award-info":[{"award-number":["P01 AG03991"]}]},{"name":"National Institute of Aging of the National Institutes of Health","award":["P01 AG026276"],"award-info":[{"award-number":["P01 AG026276"]}]},{"name":"National Institute of Aging of the National Institutes of Health","award":["P30 NS057105"],"award-info":[{"award-number":["P30 NS057105"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["P30 NS048056"],"award-info":[{"award-number":["P30 NS048056"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Center for Research Resources, NIH Roadmap for Medical Research","award":["UL1 RR024992"],"award-info":[{"award-number":["UL1 RR024992"]}]},{"DOI":"10.13039\/100001068","name":"Dana Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001068","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Charles and Joanne Knight Alzheimer Research Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2009,11,26]]},"DOI":"10.1002\/emmm.200900048","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T06:30:04Z","timestamp":1258525804000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":290,"title":["Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease"],"prefix":"10.1038","volume":"1","author":[{"given":"Anne M.","family":"Fagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Aldea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,26]]},"reference":[{"key":"BFEMMM200900048_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"H Aizenstein","year":"2008","unstructured":"Aizenstein H,Nebes R,Saxton J,Price J,Mathis C,Tsopelas N,Ziolko S,James J,Snitz B,Houck P et al(2008)Frequent amyloid deposition without significant cognitive impairment among the elderly.Arch Neurol65:1509\u20101517","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR2","first-page":"1","volume":"60","author":"S Armitage","year":"1946","unstructured":"Armitage S,(1946)An analysis of certain psychological tests used in the evaluation of brain injury.Psych Mono60:1\u201048","journal-title":"Psych Mono"},{"key":"BFEMMM200900048_CR3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/01.wnl.0000340981.97664.2f","volume":"72","author":"A Bakkour","year":"2009","unstructured":"Bakkour A,Morris J,Dickerson B,(2009)The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.Neurology72:1048\u20101055","journal-title":"Neurology"},{"key":"BFEMMM200900048_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","volume":"55","author":"L Berg","year":"1998","unstructured":"Berg L,McKeel DW,Miller JP,Storandt M,Rubin EH,Morris JC,Baty J,Coats M,Norton J,Goate AM et al(1998)Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease\u2014relation of histologic markers to dementia severity, age, sex, and apoE genotype.Arch Neurol55:326\u2010335","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12603-009-0059-0","volume":"13","author":"K Blennow","year":"2009","unstructured":"Blennow K,Meyer GD,Hansson O,Minthon L,Wallin A,Zetterberg H,Lewczuk P,Vanderstichele H,Vanmechelen E,Kornhuber J et al(2009)Evolution of Abeta42 and Abeta40 Levels and Abeta42\/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.J Nutr Health Aging13:205\u2010208","journal-title":"J Nutr Health Aging"},{"key":"BFEMMM200900048_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H,Braak E(1997)Frequency of stages of Alzheimer\u2010related lesions in different age categories.Neurobiol Aging18:351\u2010357","journal-title":"Neurobiol Aging"},{"key":"BFEMMM200900048_CR7","unstructured":"Cairns N,Ikonomovic M,Benzinger T,Storandt M,Fagan A,Shah A,Reinwald L,Carter D,Felton A,Holtzman D et al(2009)PiB\u2010PET detection of cerebral A\u03b2 may lag clinical, cognitive, and CSF markers of Alzheimer's disease: a case report.Arch Neurol (in press)"},{"key":"BFEMMM200900048_CR8","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","volume":"23","author":"J Cirrito","year":"2003","unstructured":"Cirrito J,May P,O'Dell M,Taylor J,Parsadanian M,Cramer J,Audia J,Nissen J,Bales K,Paul S et al(2003)In vivo assessment of brain interstitial fluid with microdialysis reveals plaque\u2010associated changes in amyloid\u2010\u03b2 metabolism and half\u2010life.J Neurosci23:8844\u20108853","journal-title":"J Neurosci"},{"key":"BFEMMM200900048_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2008.10.003","volume":"35","author":"R Craig\u2010Schapiro","year":"2008","unstructured":"Craig\u2010Schapiro R,Fagan A,Holtzman D,(2008)Biomarkers of Alzheimer's disease.Neurobiol Dis35:128\u2010140","journal-title":"Neurobiol Dis"},{"key":"BFEMMM200900048_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"B Dickerson","year":"2009","unstructured":"Dickerson B,Bakkour A,Salat D,Feczko E,Pacheco J,Greve D,Grodstein F,Wright C,Blacker D,Rosas H et al(2009)The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid\u2010positive individuals.Cereb Cortex19:497\u2010510","journal-title":"Cereb Cortex"},{"key":"BFEMMM200900048_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.21559","volume":"65","author":"A Fagan","year":"2009","unstructured":"Fagan A,Head D,Shah A,Marcus D,Mintun M,Morris J,Holtzman D,(2009)Decreased cerebrospinal fluid A\u03b242 correlates with brain atrophy in cognitively normal elderly.Ann Neurol65:175\u2010183","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"A Fagan","year":"2006","unstructured":"Fagan A,Mintun M,Mach R,Lee S\u2010Y,Dence C,Shah A,LaRossa G,Spinner M,Klunk W,Mathis C et al(2006)Inverse relation between in vivo amyloid imaging load and CSF A\u03b242 in humans.Ann Neurol59:512\u2010519","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"A Fagan","year":"2007","unstructured":"Fagan A,Roe C,Xiong C,Mintun M,Morris J,Holtzman D,(2007)Cerebrospinal fluid tau\/A\u03b242 ratio as a prediction of cognitive decline in nondemented older adults.Arch Neurol64:343\u2010349","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","volume":"60","author":"H Fukumoto","year":"2003","unstructured":"Fukumoto H,Tennis M,Locascio J,Hyman B,Growdon J,Irizarry M,(2003)Age but not diagnosis is the main predictor of plasma amyloid beta\u2010protein levels.Arch Neurol60:958\u2010964","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR15","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez\u2010Isla","year":"1996","unstructured":"Gomez\u2010Isla T,Price J,McKeel D,Morris J,Growdon J,Hyman B,(1996)Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.J Neurosci16:4491\u20104500","journal-title":"J Neurosci"},{"key":"BFEMMM200900048_CR16","volume-title":"Boston Naming Test scoring booklet","author":"H Goodglass","year":"1983","unstructured":"Goodglass H,Kaplan E,(1983)Boston Naming Test scoring booklet,Philadelphia, Lea & Febiger"},{"key":"BFEMMM200900048_CR17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J,Chen F,Dorpe JV,Nitsch R,(2001)Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.Science293:1491\u20101495","journal-title":"Science"},{"key":"BFEMMM200900048_CR18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"N Graff\u2010Radford","year":"2007","unstructured":"Graff\u2010Radford N,Crook J,Lucas J,Boeve B,Knopman D,Ivnik R,Smith G,Younkin L,Petersen R,Younkin S,(2007)Association of low plasma A\u03b242\/A\u03b240 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.Arch Neurol64:354\u2010362","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.38.6.900","volume":"3","author":"E Grober","year":"1988","unstructured":"Grober E,Buschke H,Crystal H,Bang S,Dresner R,(1988)Screening for dementia by memory testing.Neurology3:900\u2010903","journal-title":"Neurology"},{"key":"BFEMMM200900048_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O,Zetterberg H,Buchhave P,Londos E,Blennow K,Minthon L,(2006)Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow\u2010up study.Lancet Neurol5:228\u2010234","journal-title":"Lancet Neurol"},{"key":"BFEMMM200900048_CR21","doi-asserted-by":"publisher","unstructured":"Hansson O,Zetterberg H,Vanmechelen E,Vanderstichele H,Andreasson U,Londos E,Wallin A,Minthon L,Blennow K,(2008)Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.Neurobiol Aging, in press, doi: https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.03.027","DOI":"10.1002\/10.1016\/j.neurobiolaging.2008.03.027"},{"key":"BFEMMM200900048_CR22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","volume":"57","author":"CM Hulette","year":"1998","unstructured":"Hulette CM,Welsh\u2010Bohmer KA,Murray MG,Saunders AM,Mash DC,McIntyre LM,(1998)Neuropathological and neuropsychological changes in \u201cnormal\u201d aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.J Neuropathol Exp Neurol57:1168\u20101174","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM200900048_CR23","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"C Jack","year":"2009","unstructured":"Jack C,Lowe V,Weigand S,Wiste H,Senjem M,Knopman D,Shiung M,Gunter J,Boeve B,Kemp B et al(2009)Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.Brain132:1355\u20101365","journal-title":"Brain"},{"key":"BFEMMM200900048_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"W Klunk","year":"2004","unstructured":"Klunk W,Engler H,Nordberg A,Wang Y,Blomqvist G,Holt D,Bergstr\u00f6m M,Savitcheva I,Huang G\u2010F,Estrada S et al(2004)Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound\u2010B.Ann Neurol55:306\u2010319","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12603-009-0062-5","volume":"13","author":"D Lachno","year":"2009","unstructured":"Lachno D,Vanderstichele H,Groote GD,Kostanjevecki V,Meyer GD,Siemers E,Willey M,Bourdage J,Konrad R,Dean R,(2009)The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta\u2010amyloid isoforms using the Inno\u2010Bia Plasma Abeta Forms Multiplex Assay.J Nutr Health Aging13:220\u2010225","journal-title":"J Nutr Health Aging"},{"key":"BFEMMM200900048_CR26","doi-asserted-by":"publisher","unstructured":"Lewczuk P,Kornhuber J,Vanmechelen E,Peters O,Heuser I,Maier W,Jessen F,B\u00fcrger K,Hampel H,Fr\u00f6lich L et al(2009)Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing.Exp Neurol (in press), PMID:19664622","DOI":"10.1002\/PMID:19664622"},{"key":"BFEMMM200900048_CR27","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J,Dickson D,Lin W,Chisholm L,A A AC,Jones G,Yen S,Sahara N,Skipper L,Yager D et al(2001)Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.Science293:1487\u20101491","journal-title":"Science"},{"key":"BFEMMM200900048_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","volume":"69","author":"G Li","year":"2007","unstructured":"Li G,Sokal I,Quinn J,Leverenz J,Brodey M,Schellenberg G,Kaye J,Raskind M,Zhang J,Peskind E et al(2007)CSF tau\/A\u03b242 ratio for increased risk of mild cognitive impairment: a follow\u2010up study.Neurology69:631\u2010639","journal-title":"Neurology"},{"key":"BFEMMM200900048_CR29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J,Fowler J,Volkow N,Wang G,Ding Y,Alexoff D,(1996)Distribution volume ratios without blood sampling from graphical analysis of PET data.J Cereb Blood Flow Metab16:834\u2010840","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFEMMM200900048_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archneur.63.1.38","volume":"63","author":"W Markesbery","year":"2006","unstructured":"Markesbery W,Schmitt F,Kryscio R,Davis D,Smith C,Wekstein D,(2006)Neuropathologic substrate of Mild Cognitive Impairment.Arch Neurol63:38\u201046","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N,Zetterberg H,Hansson O,Andreasen N,Parnetti L,Jonsson M,Herukka S,Van der Flier WM,Blankenstein M,Ewers M et al(2009)CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.JAMA302:385\u2010393","journal-title":"JAMA"},{"key":"BFEMMM200900048_CR32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000090363","volume":"2","author":"P Mehta","year":"2005","unstructured":"Mehta P,Pirttila T,(2005)Increased cerebrospinal fluid Abeta38\/Abeta42 ratio in Alzheimer's disease.Neurodegener Dis2:242\u2010245","journal-title":"Neurodegener Dis"},{"key":"BFEMMM200900048_CR33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"M Mintun","year":"2006","unstructured":"Mintun M,LaRossa G,Sheline Y,Dence C,Lee S\u2010Y,Mach R,Klunk W,Mathis C,DeKosky S,Morris J,(2006)[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.Neurology67:446\u2010452","journal-title":"Neurology"},{"key":"BFEMMM200900048_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410240105","volume":"24","author":"J Morris","year":"1988","unstructured":"Morris J,McKeel D,Fulling K,Torack R,Berg L,(1988)Validation of clinical diagnostic criteria for Alzheimer's disease.Ann Neurol24:17\u201022","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"J Morris","year":"2001","unstructured":"Morris J,Price J,(2001)Pathologic correlates of nondemented aging, mild cognitive impairment, and early stage Alzheimer's disease.J Mol Neurosci17:101\u2010118","journal-title":"J Mol Neurosci"},{"key":"BFEMMM200900048_CR36","doi-asserted-by":"crossref","unstructured":"Morris J,Roe C,Grant E,Head D,Storandt M,Goate A,Fagan A,Holtzman D,Mintun M,(2009)PIB imaging predicts progression from cognitively normal to symptomatic Alzheimer's disease.Arch Neurol (in press)","DOI":"10.1001\/archneurol.2009.269"},{"key":"BFEMMM200900048_CR37","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC,(1993)The Clinical Dementia Rating (CDR). Current version and scoring rules.Neurology43:2412\u20102414","journal-title":"Neurology"},{"key":"BFEMMM200900048_CR38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S,Caccamo A,Kitazawa M,Tseng B,LaFerla F,(2003a)Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.Neurobiol Aging24:1063\u20101070","journal-title":"Neurobiol Aging"},{"key":"BFEMMM200900048_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S,Caccamo A,Shepherd J,Murphy M,Golde T,Kayed R,Metherate R,Mattson M,Akbari Y,LaFerla F,(2003b)Triple\u2010transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u00df and synaptic dysfunction.Neuron39:409\u2010421","journal-title":"Neuron"},{"key":"BFEMMM200900048_CR40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","volume":"58","author":"J Price","year":"2001","unstructured":"Price J,Ko A,Wade M,Tsou S,McKeel D,Morris J,(2001)Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease.Arch Neurol58:1395\u20101402","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL,Morris JC,(1999)Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease.Ann Neurol45:358\u2010368","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR42","doi-asserted-by":"crossref","unstructured":"Rafii M,Aisen P,(2009)Recent developments in Alzheimer's disease therapeutics.BMC Med (in press)","DOI":"10.1186\/1741-7015-7-7"},{"key":"BFEMMM200900048_CR43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2007.10.001","volume":"4","author":"S Salloway","year":"2008","unstructured":"Salloway S,Mintzer J,Weiner M,Cummings J,(2008)Disease\u2010modifying therapies in Alzheimer's disease.Alzheimers Dement4:65\u201079","journal-title":"Alzheimers Dement"},{"key":"BFEMMM200900048_CR44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.20508","volume":"58","author":"N Schoonenboom","year":"2005","unstructured":"Schoonenboom N,Mulder C,Kamp GV,Mehta S,Scheltens P,Blankenstein M,Mehta P,(2005)Amyloid \u03b2 38, 40, and 42 species in cerebrospinal fluid: more of the same?Ann Neurol58:139\u2010142","journal-title":"Ann Neurol"},{"key":"BFEMMM200900048_CR45","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","volume":"105","author":"N Schupf","year":"2008","unstructured":"Schupf N,Tang M,Fukuyama H,Manly J,Andrews H,Mehta P,Ravetch J,Mayeux R,(2008)Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease.Proc Natl Acad Sci USA105:14052\u201014057","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM200900048_CR46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","volume":"66","author":"B Snider","year":"2009","unstructured":"Snider B,Fagan A,Roe C,Shah A,Grant E,Xiong C,Morris J,Holtzman D,(2009)Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.Arch Neurol66:638\u2010645","journal-title":"Arch Neurol"},{"key":"BFEMMM200900048_CR47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","volume":"56","author":"T Sunderland","year":"2004","unstructured":"Sunderland T,Mirza N,Putnam K,Linker G,Bhupali D,Durham R,Soares H,Kimmel L,Friedman D,Bergeson J et al(2004)Cerebrospinal fluid beta\u2010amyloid \u201042 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.Biol Psychiatry56:670\u2010676","journal-title":"Biol Psychiatry"},{"key":"BFEMMM200900048_CR48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-008-0177-6","volume":"116","author":"V Welge","year":"2009","unstructured":"Welge V,Fiege O,Lewczul P,Mollenhauer B,Esselmann H,Klafki H\u2010W,Wolf S,Trenkwalder C,Otto M,Kornhuber J et al(2009)Combined CSF tau, p\u2010tau181 and amyloid\u2010\u03b2 38\/40\/42 for diagnosing Alzheimer's disease.J Neural Transm116:203\u2010212","journal-title":"J Neural Transm"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.200900048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emmm.200900048","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1002\/emmm.200900048\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1002\/emmm.200900048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.200900048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:57:37Z","timestamp":1779083857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1002\/emmm.200900048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,26]]},"references-count":48,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2009,11,26]]}},"alternative-id":["BFEMMM200900048"],"URL":"https:\/\/doi.org\/10.1002\/emmm.200900048","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1560959.1051058","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,26]]},"assertion":[{"value":"16 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}